ORCID as entered in ROS

Select Publications
2024, 'Clinical impact of molecular profiling in the national prospective cohort Solving Unknown Primary Cancer (SUPER) study', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 42, presented at Special Clinical Science Symposia, ELECTR NETWORK, 29 May 2024 - 29 May 2024
,2024, '366P Clinicopathological predictors of favourable response to docetaxel in patients with metastatic castration-resistant prostate cancer', in Annals of Oncology, Elsevier BV, Vol. 35, pp. S1541 - S1541, http://dx.doi.org/10.1016/j.annonc.2024.10.385
,2024, 'AGITG MONARCC: A randomized phase 2 study of panitumumab monotherapy and panitumumab (pan) plus 5 fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer—A trial by the Australasian Gastro-Intestinal Trials Group (AGITG).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 42, pp. 3535 - 3535, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3535
,2024, 'Cancer of Unknown Primary-Shining light into the unknown', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 108 - 109
,2024, 'This is Me: Revision of a co-designed resource to communicate what matters most to older adults with cancer when treatment decisions are being considered', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 214 - 215
,2024, 'Working towards equitable age-friendly care among older adults in regional cancer care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 109 - 109
,2022, 'Regional Victorian trials alliance: Linkages, Innovation, Special populations, Equity (ReViTALISE) project: Addressing disparity in regional populations', in Asia Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 87 - 87, presented at COSA's 49th Annual Scientific Meeting, 02 November 2022 - 04 November 2022, https://onlinelibrary.wiley.com/doi/10.1111/ajco.13868
,2022, 'Solving unknown primary cancer - Earlier diagnosis (SUPER-ED): A stepped wedge cluster randomised controlled trial implementing a Model of Care to support earlier diagnosis', in Asia Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 143 - 144, presented at COSA's 49th Annual Scientific Meeting, 02 November 2022 - 04 November 2022, https://onlinelibrary.wiley.com/doi/10.1111/ajco.13869
,2022, 'Changing landscape of lung cancer survival in a regional Australian centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 160 - 160
,2022, 'Geriatric assessment (GA) in the instagram era: Adding photographs to electronic ga to enhance supportive care (ESC) of older adults with cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 224 - 224
,2022, 'Stigma and ageism - The challenges of delivering appropriate care to older adults with NSCLC', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 105 - 105
,2022, 'The utility of molecular tumour profiling for patients with advanced cancer in a regional Australian setting', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 151 - 151
,2021, 'Durability of response to immune checkpoint inhibitors (ICI) in metastatic Merkel cell carcinoma (mMCC) after treatment cessation.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.9543
,2021, 'Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903)', in Gynecologic Oncology, Vol. 161, pp. 160 - 165, http://dx.doi.org/10.1016/j.ygyno.2021.02.016
,2020, 'MONARCC: A randomized phase II study of panitumumab monotherapy and panitumumab (pan) plus 5 Fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer (mCRC): An AGITG clinical trial', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 38, presented at Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, CA, San Francisco, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530922700257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Exercise and androgen deprivation therapy: Current practice and future direction at a regional cancer centre', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide, pp. 198 - 198, presented at 2019 COSA 46th Annual Scientific Meeting, Adelaide, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13263
,2019, 'Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 37, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2019 - 04 June 2019, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.3072
,2017, 'INCORPORATING GERI-ONCOLOGY ASSESSMENTS IN GU RESEARCH', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 13, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427541700040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,